FDA Warning Letter — InfuScience, Inc. dba Bioscrip Infusion Services
The FDA took a Warning Letter action against InfuScience, Inc. dba Bioscrip Infusion Services on December 21, 2020 (Chantilly, VA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- InfuScience, Inc. dba Bioscrip Infusion Services
- Date
- December 21, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Center
- CDER
- Location
- Chantilly, VA (United States)